A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Are Thermo Fisher Shares a Fair Deal After Key Pharma Partnerships and 14% Price Surge? - Yahoo Finance
Are Thermo Fisher Shares a Fair Deal After Key Pharma Partnerships and 14% Price Surge? Yahoo Finance
Other news to note for Nov. 25, 2025
Biopharma happenings in Asia-Pacific including deals and partnerships, grants, preclinical data and other news in brief: Actimed, Aptose, Austrianova, Avant, Celltrion,...
UK-US drug pricing deal could come as early as this week, sources say
A major drug price deal between the US and UK government could be finalized as early as this week, two UK-based sources familiar with the matter told Endpoints News on...
Other news to note for Nov. 24, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: C2N Diagnostics, Clearside, Danaher, DK Healthcare, Fize, Leica...
Other news to note for Nov. 24, 2025
Biopharma happenings, including deals and partnerships, and other news in brief: Actimed, Anaptysbio, GSK, Lava, Tesaro, Xoma.
Pharma faces a critical ‘turning point’ in 2026, years in the making
While Trump’s manufacturing and pricing deals with pharma shape the industry’s future, COVID’s impact still ripples throughout the health landscape.
Roche inks deal for rights to Freenome cancer tests outside US - MedTech Dive
Roche inks deal for rights to Freenome cancer tests outside US MedTech Dive
Roche pens $1B biobucks deal for Chinese company's respiratory disease bispecific - Fierce Biotech
Roche pens $1B biobucks deal for Chinese company's respiratory disease bispecific Fierce Biotech
Thermo Fisher lifts annual forecasts on tools demand, recent deals - Reuters
Thermo Fisher lifts annual forecasts on tools demand, recent deals Reuters
Roche dives into MASH with $2.4B deal for 89bio - BioPharma Dive
Roche dives into MASH with $2.4B deal for 89bio BioPharma Dive
Illumina to buy SomaLogic in deal worth up to $425M - BioPharma Dive
Illumina to buy SomaLogic in deal worth up to $425M BioPharma Dive
Cytiva Picks Up Where GE Leaves Off after $21B Deal - GEN - Genetic Engineering and Biotechnology News
Cytiva Picks Up Where GE Leaves Off after $21B Deal GEN - Genetic Engineering and Biotechnology News
Cytiva rises out of GE Healthcare as Danaher completes $21bn deal - BioProcess International
Cytiva rises out of GE Healthcare as Danaher completes $21bn deal BioProcess International
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page